A clinical feasibility study to evaluate the effectiveness and safety of VivescOs™ as bone graft for reconstruction of intra-oral osseous defects
Completed
- Conditions
- Intra-oral bone defects, loss of teeth/molarsMusculoskeletal Diseases
- Registration Number
- ISRCTN92152389
- Lead Sponsor
- IsoTis NV (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Repair of the intra-oral defect was indicated as preparation for dental implant placement in a secondary stage.
Exclusion Criteria
1. Presence of local or systemic disease;
2. Pregnancy, cancertherapy;
3. Previous participation in another trial within 30 days;
4. Known hypersensitivity for penicillin, streptomycin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method